Data for (Study ST000669)

(Analysis AN001024)

Values for each metabolite have been scaled by dividing by the mean across all factors

Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

MetaboliteF1F2F3F4
Arachidonic acid 0.1325 0.2539 2.2536 0.1064
CL 70:1; [M-2H](2-)@6.90 1.0131 0.3122 1.6658 0.3431
CL 70:3; [M-2H](2-)@6.51 1.8622 0.2827 0.7629 1.3293
CL 74:1; [M-2H](2-)@7.50 0.3976 0.2374 2.0583 0.2484
CL 74:5; [M-2H](2-)@6.58 1.1494 0.5803 1.0007 1.2688
CL 74:7; [M-2H](2-)@6.26 1.1055 0.8468 1.0224 1.0029
CL 78:3; [M-2H](2-)@7.53 0.9017 0.3493 1.5694 0.6103
CL 78:5; [M-2H](2-)@7.28 0.6486 0.6902 1.4010 0.8592
CL 82:11; [M-2H](2-)@6.93 0.4803 2.4170 0.8338 0.4351
CL 82:13; [M-2H](2-)@6.48 0.3134 1.4281 1.3931 0.4723
FFA(16:0) 0.9549 0.7458 1.2154 0.8686
FFA(18:0) 0.9337 0.9387 1.0950 0.9377
FFA(18:1) 1.2221 0.1980 1.3371 0.9058
FFA(18:2) 1.5394 0.0890 1.2042 0.9633
FFA(20:0) 1.0270 1.0097 1.0925 0.7782
FFA(20:1) 0.4897 0.1542 1.9968 0.3625
FFA(20:2) 0.2722 0.0561 2.1870 0.2978
FFA(22:0) 0.7233 0.7083 1.4003 0.7677
FFA(22:1) 0.3819 0.2760 1.9803 0.3816
FFA(22:2) 0.1375 0.1007 2.2963 0.1693
FFA(22:3) 0.0944 0.0717 2.3786 0.0767
FFA(24:0) 0.7943 0.4477 1.5892 0.5796
FFA(24:1) 0.1200 0.0180 2.3943 0.0735
FFA(24:2) 0.1427 0.0160 2.3578 0.1257
FFA(24:3) 0.0779 0.1064 2.3589 0.0978
IS PA 34:0 ;[M-H]- 0.4219 0.5649 2.9290 0.0842
IS PC 34:0;[M-Ac-H]- 1.2389 0.0688 1.1967 1.2989
IS PE 34:0 ;[M-H]- 0.9765 1.2761 0.9191 0.9093
IS PG 34:0 ;[M-H]- 0.6996 0.7142 1.3752 0.8357
IS PI 37:4 ;[M-H]- 0.6173 1.9564 0.7372 0.9520
IS PS 34:0 ;[M-H]- 0.6130 1.4711 1.0252 0.8656
lysoPE 16:0; [M-H]-@1.69 1.6568 0.2797 0.9783 1.1069
lysoPE 18:0; [M-H]-@2.50 0.7617 0.2008 1.8242 0.3892
lysoPE 18:1; [M-H]-@1.85 2.4564 0.0825 0.7251 1.0110
lysoPE 18:2; [M-H]-@1.40 2.4210 NA 0.1352 1.3086
lysoPE 20:3; [M-H]-@1.68 2.2292 0.6185 0.5134 1.1254
lysoPE 20:4; [M-H]-@1.37 2.8254 0.0482 0.2424 1.6415
lysoPE 22:5; [M-H]-@1.60 1.9492 NA 0.3671 1.3165
lysoPE 22:6; [M-H]-@1.31 2.6739 0.1204 0.1943 1.8172
lysoPE 24:0; [M-H]-@5.28 0.0776 0.0120 2.4322 0.0460
PA 34:0; [M-H]-@6.77 1.2454 1.6116 NA 0.1430
PA 34:3; [M-H]-@0.69 0.2954 2.0587 0.3336 1.9786
PC 31:0; [M-Ac-H]-@6.67 0.1906 0.3760 1.9933 0.4468
PC 32:0; [M-Ac-H]-@6.91 0.2168 0.3855 2.0603 0.2771
PC 32:1; [M-Ac-H]-@6.38 0.5807 0.9425 1.4546 0.5677
PC 32:2; [M-Ac-H]-@5.85 1.9953 0.0100 0.4466 2.1015
PC 33:1; [M-Ac-H]-@6.73 1.0493 0.3204 1.1944 1.2416
PC 33:2; [M-Ac-H]-@6.21 1.9981 0.0542 0.9738 NA
PC 34:0; [M-Ac-H]-@7.64 0.8563 1.4889 0.8570 0.9410
PC 34:1; [M-Ac-H]-@7.00 1.1237 0.2568 1.3121 0.9954
PC 34:1; [M-Ac-H]-@9.62 NA 0.4635 1.2683 NA
PC 34:2; [M-Ac-H]-@6.49 2.0266 0.1850 0.4746 1.8392
PC 34:3; [M-Ac-H]-@6.06 2.3241 0.0389 0.4211 1.7947
PC 34:4; [M-Ac-H]-@5.80 1.5738 0.2939 0.6711 1.7903
PC 35:1; [M-Ac-H]-@7.36 1.1710 0.2171 1.2006 1.2107
PC 35:2; [M-Ac-H]-@6.89 2.0844 0.0815 0.3383 1.4958
PC 35:4; [M-Ac-H]-@6.12 1.5011 0.2728 1.0025 1.2236
PC 36:1; [M-Ac-H]-@7.71 1.4226 0.4496 1.0227 1.0824
PC 36:2; [M-Ac-H]-@7.19 1.7340 0.1644 0.7169 1.6678
PC 36:3; [M-Ac-H]-@6.67 1.8177 0.2018 0.5747 1.8312
PC 36:4; [M-Ac-H]-@6.33 1.7081 0.3508 0.6398 1.6616
PC 36:4; [M-Ac-H]-@6.69 1.7081 0.3508 0.6398 1.6616
PC 36:5; [M-Ac-H]-@5.89 1.9977 0.0549 0.1621 1.7853
PC 36:6; [M-Ac-H]-@5.71 1.6177 0.7623 0.4760 1.6679
PC 37:3; [M-Ac-H]-@6.98 1.5915 0.3373 0.9143 1.2427
PC 37:4; [M-Ac-H]-@6.84 1.7492 0.2288 0.8815 1.2589
PC 38:2; [M-Ac-H]-@7.86 1.0523 0.2282 1.3115 1.0965
PC 38:3; [M-Ac-H]-@7.42 1.4492 0.1850 0.7693 1.8271
PC 38:4; [M-Ac-H]-@7.04 1.7097 0.2812 0.8235 1.3620
PC 38:4; [M-Ac-H]-@7.37 1.7097 0.2812 0.8235 1.3620
PC 38:5; [M-Ac-H]-@6.60 1.6311 0.3281 0.6474 1.7460
PC 38:6; [M-Ac-H]-@6.28 1.5021 0.2535 0.6285 1.9873
PC 40:4; [M-Ac-H]-@7.70 1.1552 0.3560 1.2961 0.8966
PC 40:5; [M-Ac-H]-@7.29 1.1691 0.2708 0.8012 1.9577
PC 40:6; [M-Ac-H]-@7.00 0.9515 0.6140 0.8927 1.6491
PC 40:7; [M-Ac-H]-@6.38 1.0336 0.6753 1.0650 1.1611
PC 42:4; [M-Ac-H]-@8.22 0.6175 0.0409 1.9881 0.3655
PC 42:5; [M-Ac-H]-@7.89 1.0202 0.0574 1.6972 0.5280
PE 32:0; [M-H]-@6.76 0.1583 1.2193 1.6767 0.2689
PE 34:0; [M-H]-@7.36 0.9657 1.2896 0.9133 0.9181
PE 34:1; [M-H]-@6.90 0.8171 0.1894 1.7770 0.4394
PE 34:2; [M-H]-@6.45 1.8469 0.2932 0.6430 1.5739
PE 34:3; [M-H]-@6.04 1.2560 0.1980 0.8805 1.7848
PE 36:0; [M-H]-@7.96 0.4053 0.7197 1.3187 1.2376
PE 36:1; [M-H]-@5.84 0.0917 NA 1.9338 0.0407
PE 36:1; [M-H]-@7.50 0.3920 0.3014 1.9869 0.3329
PE 36:2; [M-H]-@5.42 0.3113 0.0685 2.2135 0.1933
PE 36:2; [M-H]-@7.03 1.0418 0.2456 1.2836 1.1454
PE 36:3; [M-H]-@6.59 1.1106 0.5876 1.0290 1.2438
PE 36:4; [M-H]-@6.31 1.0121 0.9829 0.9704 1.0641
PE 36:5; [M-H]-@6.03 1.2265 0.2848 0.8483 1.7922
PE 37:4; [M-H]-@6.71 0.7702 0.6184 0.9384 1.7346
PE 38:2; [M-H]-@7.57 0.4193 0.3162 2.2645 NA
PE 38:3; [M-H]-@7.29 0.6669 0.7765 1.3868 0.7829
PE 38:4; [M-H]-@7.04 0.7358 0.8982 1.2721 0.8218
PE 38:5; [M-H]-@6.53 0.8565 0.9028 0.9783 1.2840
PE 38:6; [M-H]-@6.31 0.8452 0.7040 1.2013 1.0482
PE 40:4; [M-H]-@7.45 NA 0.7262 1.1369 NA
PE 40:5; [M-H]-@6.17 0.6921 0.1547 1.5766 NA
PE 40:6; [M-H]-@6.94 0.6068 1.8926 0.8995 0.7015
PE 40:7; [M-H]-@6.41 0.4224 1.4722 1.3708 0.3639
PE 40:8; [M-H]-@6.02 0.5656 0.9177 1.5876 0.3415
PG 34:0; [M-H]-@6.22 0.6996 0.7142 1.3752 0.8357
PG 36:0; [M-H]-@6.77 0.4136 1.3665 NA 1.2199
PG 36:2; [M-H]-@5.56 0.0148 0.2698 2.2369 0.2415
PG 36:3; [M-H]-@5.13 0.0515 0.2859 2.3119 0.0389
PG 38:3; [M-H]-@5.76 0.2374 0.4464 1.9850 0.3463
PG 38:4; [M-H]-@5.33 0.0410 0.7512 2.0925 0.0228
PG 38:5; [M-H]-@5.09 0.0359 0.7245 2.0833 0.0731
PG 38:6; [M-H]-@4.69 0.0395 1.2903 1.7884 0.0934
PG 40:5; [M-H]-@5.47 0.0452 0.8160 2.0664 0.0061
PG 40:6; [M-H]-@5.25 0.0906 0.8356 2.0235 0.0267
PG 40:7; [M-H]-@4.98 0.0344 0.7163 2.1124 0.0245
PG 40:8; [M-H]-@4.55 0.0629 0.7182 2.1076 0.0036
PG 42:10; [M-H]-@4.48 0.0683 0.7285 1.6016 NA
PG 44:10; [M-H]-@5.11 0.0164 1.2040 1.8466 0.0863
PG 44:11; [M-H]-@4.76 0.1025 2.4157 1.1841 0.1136
PG 44:12; [M-H]-@4.34 0.0508 0.6008 1.6742 NA
PG 44:9; [M-H]-@5.30 0.5754 1.6866 0.9561 0.8258
PI 34:1; [M-H]-@5.52 0.9094 1.0519 1.2267 0.5852
PI 34:2; [M-H]-@5.09 1.6708 0.0503 0.8166 1.6457
PI 36:1; [M-H]-@6.12 1.1932 0.0111 1.3307 1.1344
PI 36:2; [M-H]-@5.75 1.3857 0.0684 1.0676 1.4107
PI 36:3; [M-H]-@5.20 0.7113 0.4433 1.4868 0.8718
PI 36:4; [M-H]-@5.06 1.1025 0.9507 1.0423 0.8621
PI 37:4; [M-H]-@5.39 0.6204 1.9795 0.7187 0.9626
PI 38:3; [M-H]-@6.01 1.0242 0.3437 1.2098 1.2126
PI 38:4; [M-H]-@5.77 0.8269 0.6512 1.3146 0.8926
PI 38:5; [M-H]-@5.22 0.7095 0.7539 1.3929 0.7507
PI 40:4; [M-H]-@6.16 0.6306 0.3202 1.8029 0.4433
PI 40:6; [M-H]-@5.63 0.4908 0.3957 1.7100 0.6935
plasmenyl-PE 32:1; [M-H]-@6.66 0.6628 0.1252 1.7446 0.7228
plasmenyl-PE 34:1; [M-H]-@7.24 0.7984 0.2750 1.6432 0.6402
plasmenyl-PE 34:2; [M-H]-@6.80 1.6067 0.0651 0.6551 2.0181
plasmenyl-PE 36:1; [M-H]-@7.80 1.5145 0.1095 1.2536 0.8687
plasmenyl-PE 36:2; [M-H]-@7.40 1.5978 0.0971 1.0443 1.2164
plasmenyl-PE 36:3; [M-H]-@6.99 1.4416 0.3859 0.9159 1.3406
plasmenyl-PE 36:4; [M-H]-@6.74 1.0133 0.2403 1.3467 1.0530
plasmenyl-PE 36:5; [M-H]-@6.33 0.9093 0.0981 1.3746 1.2435
plasmenyl-PE 38:2; [M-H]-@7.98 0.5642 0.0233 1.5449 1.3228
plasmenyl-PE 38:3; [M-H]-@7.60 1.1738 0.5525 1.2980 0.6777
plasmenyl-PE 38:4; [M-H]-@7.31 1.0819 0.3682 1.4430 0.6639
plasmenyl-PE 38:5; [M-H]-@6.77 1.1404 0.2050 1.3796 0.8954
plasmenyl-PE 38:6; [M-H]-@6.61 1.1187 0.1868 1.2621 1.1702
plasmenyl-PE 40:4; [M-H]-@7.79 0.8868 0.1860 1.6963 0.5345
plasmenyl-PE 40:5; [M-H]-@7.47 0.7033 0.4974 1.6324 0.5346
plasmenyl-PE 40:6; [M-H]-@7.25 1.0351 0.4016 1.3652 0.8330
plasmenyl-PE 42:6; [M-H]-@7.81 0.8587 0.0429 1.1390 1.9595
PS 34:0; [M-H]-@6.19 0.5028 1.4274 1.1482 0.7734
Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study

Factors:

F1Disease:AS-Control-P | Matrix:Plasma | Sample type:Plasma
F2Disease:AS-Control-S | Matrix:SRF | Sample type:Fluids and Secretions
F3Disease:Coats | Matrix:CB | Sample type:Fluids and Secretions
F4Disease:JB-Coats-P | Matrix:Plasma | Sample type:Plasma
  logo